SIGA TECHNOLOGIES INC. - COMMON STOCK

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2022

04 авг 2022 16:05:07 Источник Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results

28 июл 2022 16:15:00 Источник Nasdaq GlobeNewswire

SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics

15 июл 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)

12 июл 2022 16:15:00 Источник Nasdaq GlobeNewswire

SIGA Technologies Receives Approval from UK for Tecovirimat

08 июл 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)

23 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire

SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022

22 июн 2022 10:13:44 Источник Nasdaq GlobeNewswire

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)

19 май 2022 07:30:00 Источник Nasdaq GlobeNewswire

New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX®

12 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2022

05 май 2022 16:05:02 Источник Nasdaq GlobeNewswire

SIGA Declares Special Dividend of $0.45 Per Share

05 май 2022 07:30:01 Источник Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 5th, 2022 Following Release of First Quarter 2022 Financial Results

28 апр 2022 16:05:02 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021

03 мар 2022 16:05:01 Источник Nasdaq GlobeNewswire

SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials

02 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 3rd, 2022 Following Release of Fourth Quarter and Full Year 2021 Financial Results

24 фев 2022 10:27:12 Источник Nasdaq GlobeNewswire

SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech

25 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022

18 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat

10 янв 2022 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®

01 дек 2021 09:55:02 Источник Nasdaq GlobeNewswire

European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat

16 ноя 2021 08:30:00 Источник Nasdaq GlobeNewswire